CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE Discovers Six New Rare Diseases by Leveraging the Strength of Its Bio/Databank

Research leads to diagnosis and treatment options for rare disease patients

Read more

CENTOGENE Reports Record Fourth Quarter and Full Year 2020 Financial Results

Delivers very strong financial results in unprecedented year

Read more

CENTOGENE Extends Partnership With Takeda

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 14, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused…

Read more

CENTOGENE to Announce Full Year 2020 Financial Results on April 15, 2021

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, April 8, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused…

Read more

CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson’s Disease Study

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 9, 2021 (GLOBE NEWSWIRE)

  • Rostock International Parkinson's Disease (ROPAD) Study aims to…

Read more

Science meets Culture: CENTOGENE Rare Disease Day

Virtuelle Konferenz und -Filmfestival 2021 am 28. Februar 2021

Read more

Science Meets Culture: CENTOGENE’s Rare Disease Day 2021 Activities

Virtual Conference and Filmfestival on February 28, 2021

Read more

CENTOGENE Announces Voting Results of Extraordinary General Meeting

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, December 18, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”),…

Read more

CENTOGENE Reports Third-Quarter 2020 Financial Results and Increases Full Year Guidance

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, December 16, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”),…

Read more

CENTOGENE to Report Third-Quarter 2020 Financial Results on December 16, 2020

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, December 09, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company…

Read more

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads